Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook
twitter
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
Medicine Availability
Support

Home > News & Updates > Regulatory Updates > Pharmacovigilance > DRAP notified Pharmacovigilance Risk Assessment Expert Committee (PRAEC) under the Pharmacovigilance Rules, 2022

DRAP notified Pharmacovigilance Risk Assessment Expert Committee (PRAEC) under the Pharmacovigilance Rules, 2022

Asad Ullah Pharmacovigilance June 20, 2022September 28, 2022

PRAEC Notification (10.06.2022)Download

Share this:

Twitter
Facebook

← Proposed amendments in the Rules : DRAP invites comments from stakeholders and public on the draft amendments in the Drugs (Licensing, Registering and Advertising) Rules, 1976;
Minutes of 286th Meeting of Central Licensing Board held on 11th May 2022 →

Drugs
Medical Devices
Alternative Medicines
Controlled Substances
Licensing and Inspections
Clinical Trials
Pharmacovigilance
Advertisements
General

Quick Navigation

Quick Navigation

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:30AM to 04:30PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem